Huperzine A is sold under the brand name Cerebra and is the primary ingredient in Parasym Plus, a dietary supplement marketed for Ehlers Danlos Syndrome, postural orthostatic tachycardia (POTS), and mast cell activation disorder.
Theory[edit | edit source]
Evidence[edit | edit source]
Huperzine A may improve memory and thinking, for example in Alzheimer's disease, but evidence is very limited.
Clinicians[edit | edit source]
Risks and safety[edit | edit source]
Costs and availability[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
- Huperzine A - WebMD
References[edit | edit source]
- Wang, Bai-song; Wang, Hao; Wei, Zhao-hui; Song, Yan-yan; Zhang, Lu; Chen, Hong-zhuan (April 1, 2009). "Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis". Journal of Neural Transmission. pp. 457–465. doi:10.1007/s00702-009-0189-x. ISSN 0300-9564. Retrieved November 9, 2016.